Our vision is to be a world-class commercial biotechnology company. We believe that we can achieve this with an approach of focused excellence in everything that we do-in working efficiently, in making data-driven decisions quickly, and in advancing promising compounds rapidly. Already, we have built one of the most impressive oncology development pipelines in the biotechnology and pharmaceutical industries.
More >>

Date Title   05/15/13 Reminder: Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting 05/08/13 Exelixis Announces Webcasts of Upcoming Investor Conference Presentations 05/07/13 Exelixis Announces First Quarter 2013 Financial Results 05/07/13 Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting

Exelixis, Inc. at UBS Global Healthcare Conference Tuesday, May 21, 2013 9:30 a.m. ET Location Sheraton New York Hotel New York, NY US Add to Calendar   remind me days before the event Exelixis, Inc. at American Society of Clinical Oncology (ASCO) 2013 Annual Meeting Sunday, June 2, 2013 6:00 p.m. CT Add to Calendar   remind me days before the event Enter your e-mail address

2012 Annual Report (pdf) 2011 Annual Report (pdf)

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.